| Product Name | MF | CAS | Details |
|---|
| EDI048 | C25H21ClN4O4 | 2767264-57-1 | Details |
| (S)-Bexicaserin | C15H19F2N3O | 2035818-21-2 | Details |
| Atrosab | 1365659-05-7 | Details |
| CDK7-IN-25 | 2009209-60-1 | Details |
| DGKα&ζ-IN-1 | C29H31FN8O2 | 2830643-06-4 | Details |
| pan-KRAS-IN-3 | C33H32F3N5O2 | 2875116-29-1 | Details |
| RET-IN-25 | 2965703-02-8 | Details |
| STAT3-IN-18 | C18H24Cl2N2O6Pt | 2668267-41-0 | Details |
| Bocodepsin | C26H39N5O6S2 | 1834513-65-3 | Details |
| 5-HT2A&5-HT2C agonist-1 | 1640-02-4 | Details |
| Aneratrigine | C19H20ClF2N5O2S2 | 2097163-74-9 | Details |
| Cbl-b-IN-12 | C28H29F3N6O2 | 2851871-29-7 | Details |
| Tubulin polymerization-IN-52 | 2108615-05-8 | Details |
| HPK1-IN-37 | C27H35N7O4 | 2766481-68-7 | Details |
| RUNX-IN-1 | C71H88Cl2N24O11 | 2177285-35-5 | Details |
| pan-KRAS-IN-4 | 2885961-55-5 | Details |
| Icalcaprant | C23H26N4O3 | 2227384-17-8 | Details |
| N-Acetyl-L-arginine | C8H16N4O3 | 155-84-0 | Details |
| 5-HT2 agonist-1 free base | 2708279-77-8 | Details |
| HSD17B13-IN-2 | C21H23F2NO4 | 863564-24-3 | Details |
| PI3Kδ-IN-13 | 1686137-02-9 | Details |
| Arbemnifosbuvir | C24H33FN7O7P | 1998705-63-7 | Details |
| DGKα-IN-6 | C25H21F3N6 | 2886734-91-2 | Details |
| S1P1 agonist 6 hemicalcium | 2941310-03-6 | Details |
| Lacutoclax | C48H55ClN8O7S | 2291166-56-6 | Details |
| AMB639752 | C21H23N3O3 | 371210-26-3 | Details |
| TRK-IN-24 | 2937544-01-7 | Details |
| αvβ1 integrin-IN-2 | C29H38N4O4 | 2234874-68-9 | Details |
| ROCK-IN-9 | C20H20FN5O2 | 2643334-76-1 | Details |
| Votoplam | C21H25N9O | 2407849-89-0 | Details |
| JAK-IN-31 | 2597016-88-9 | Details |
| Laxiflorin B | C20H24O5 | 165337-71-3 | Details |
| PHD-IN-2 | 2924182-42-1 | Details |
| Friluglanstat | C25H20ClF3N4O3 | 1422203-86-8 | Details |
| CRF1 receptor antagonist-1 | 2635364-30-4 | Details |
| Anticancer agent 143 | C19H15BrF2N3O6PS2 | 2948339-38-4 | Details |
| Antibacterial agent 159 | C51H50N16O10S6 | 2804044-53-7 | Details |
| 5-HT2C agonist-3 free base | 2104810-17-3 | Details |
| FIKK9.1-IN-1 | 1448523-50-9 | Details |
| 5-HT2 agonist-1 | C19H22N2O2.ClH | 2708279-78-9 | Details |
| ROCK-IN-8 | 1621103-79-4 | Details |
| Zndm19 | C13H13N3OS2 | 364055-05-0 | Details |
| DUB-IN-7 | C17H19N5O | 2894064-79-8 | Details |
| Oxynitidine | C21H17NO5 | 548-31-2 | Details |
| JAK kinase-IN-1 | C17H19F2N7OS | 2698389-43-2 | Details |
| HPK1-IN-38 | 2578802-72-7 | Details |
| Bocodepsin hydrochloride | C26H39N5O6S2.ClH | 1834513-66-4 | Details |
| HSD17B13-IN-3 | C22H21NO6S2 | 313259-88-0 | Details |
| Cbl-b-IN-8 | C35H44F3N7O3 | 2815223-33-5 | Details |
| pan-KRAS-IN-2 | C34H34F2N4O3 | 2882825-14-9 | Details |
| RUNX-IN-2 | C71H88Cl2N24O11 | 2893777-88-1 | Details |
| Frunexian | C19H26N4O4 | 1803270-60-1 | Details |
| DPP | C36H40Cl2N2O10Pt | 2668267-47-6 | Details |
| Beclin1-ATG14L interaction inhibitor 1 | C23H24N4O5S | 1243063-73-1 | Details |
| Cbl-b-IN-11 | C31H35F5N6O | 2815225-15-9 | Details |
| USP1-IN-6 | C29H27F3N8O | 2925547-95-9 | Details |
| PHD-IN-1 | 2924182-31-8 | Details |
| Cbl-b-IN-7 | C29H31F4N5O2 | 2815221-35-1 | Details |
| Bavtavirine | C26H20N6 | 1956373-71-9 | Details |
| ON 108600 | C22H14Cl2N2O6S2 | 1585246-23-6 | Details |
| Cbl-b-IN-9 | C30H33F3N6O2 | 2815223-41-5 | Details |
| Cbl-b-IN-13 | C29H30F3N5O2 | 2368841-85-2 | Details |
| USP1-IN-5 | C27H23F3N8O | 2925547-94-8 | Details |
| Tacaciclib | C30H36N6O3 | 2768774-66-7 | Details |
| Zevotrelvir | C28H26F3N5O3 | 2773516-53-1 | Details |
| Igermetostat | C32H46N4O4 | 2409538-60-7 | Details |
| Cbl-b-IN-10 | C31H37F3N6O | 2815225-12-6 | Details |
| Anticancer agent 144 | 2948340-59-6 | Details |
| Androgen receptor degrader-3 | C45H51ClN8O5 | 2753650-84-7 | Details |
| Risevistinel | C14H23N3O4 | 2591344-26-0 | Details |
| GRK2 Inhibitor 2 | C19H16N4O2 | 2592436-21-8 | Details |
| c-Fms-IN-14 | 1898210-99-5 | Details |
| BQZ-485 | C32H39NO3 | 1906915-49-8 | Details |
| Cinsebrutinib | 2724962-58-5 | Details |
| TNIK&MAP4K4-IN-1 | C25H23FN4O3 | 2478592-86-6 | Details |
| 9-Chloromethyl-10-hydroxy-11-F-Camptothecin | C22H18ClFN2O4 | 2414594-22-0 | Details |
| Immunosuppressant-1 | C14H12BrNO3 | 1224571-03-2 | Details |
| m-Se3 | C29H23N2Se.I | 2829939-44-6 | Details |
| DQP-26 | C28H21Cl2N3O4 | 1449373-99-2 | Details |
| FGFR4-IN-16 | 1970120-44-5 | Details |
| Z-LVG | C21H31N3O6 | 119670-31-4 | Details |
| Keap1-Nrf2-IN-16 | C73H114N16O26 | 1362661-40-2 | Details |
| ZINC49534341 | C12H9N3OS2 | 1274013-03-4 | Details |
| BTK-IN-27 | 1841502-36-0 | Details |
| Tibremciclib | C28H32F2N8 | 2397678-18-9 | Details |
| WLB-89462 | C21H29N5O3 | 2849471-75-4 | Details |
| GPR55 agonist 3 | C19H16F4N4 | 3006105-44-5 | Details |
| Cbl-b-IN-6 | C30H32F5N5O | 2815221-33-9 | Details |
| Antibacterial agent 158 | 2804045-21-2 | Details |
| Anticancer agent 142 | C13H14BrF2N2O7PS2 | 2948338-60-9 | Details |
| DGKα-IN-7 | 2886092-50-6 | Details |
| HBV-IN-38 | 1834483-86-1 | Details |
| hCAIX/XII-IN-8 | 59994-64-8 | Details |
| S1P1 agonist 6 | 2433782-42-2 | Details |
| HBV-IN-41 | 1967002-25-0 | Details |
| SIRT6-IN-3 | C21H29Br2N6S.Br.ClH | 3023471-40-8 | Details |
| Cyclophellitol aziridine | C7H13NO4 | 136861-97-7 | Details |
| Nevadistinel | C15H18N2O3 | 2181816-92-0 | Details |
| Porcn-IN-2 | C24H17F3N6O | 1900754-65-5 | Details |
| 5-HT2C agonist-3 | 2104810-18-4 | Details |
| Product Total： Product Page： | ||||
| 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||